Bridge to Life to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Duluth, GA – March 12, 2026 - Bridge to Life™ Ltd., a global leader in organ preservation technologies for transplant medicine, announced that President and Chief Executive Officer Don Webber and Chief Financial Officer Brian Lenz will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference, taking place virtually from March 16–19, 2026.
Bridge to Life’s presentation will be held virtually on Wednesday, March 18, 2026, from 2:00 p.m. to 2:30 p.m. ET.
During the presentation, company leadership will provide an overview of Bridge to Life’s continued commercial growth, recent regulatory milestones, and strategic initiatives supporting the company’s evolution into a fully integrated medical device manufacturer. The discussion will highlight the company’s expanding portfolio of organ preservation and perfusion technologies, including the recent FDA cleared VitaSmart™ Liver Perfusion System, as well as the company’s broader strategy to build a global platform supporting transplant centers and improving transplant outcomes.
The Oppenheimer Healthcare MedTech & Services Conference brings together leading healthcare companies, institutional investors, and industry experts to discuss emerging technologies and investment opportunities across the healthcare sector.
Bridge to Life™ remains focused on advancing technologies that improve organ preservation, expand the availability of transplantable organs, and support transplant teams worldwide.
About Bridge to Life™ Ltd
Bridge to Life™ Ltd. is a global leader in organ preservation solutions, offering a comprehensive portfolio that includes Belzer UW®, EasiSlush®, and the VitaSmart™ Hypothermic Oxygenated Perfusion System. Bridge to Life partners with transplant centers and organ procurement organizations worldwide to advance preservation science and support life-saving transplantation.
For more information, visit www.bridgetolife.com.
